Le Lézard
Classified in: Business
Subject: v

M Split Corp. Monthly Dividend Declared for Class I Preferred Shares


TORONTO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- M Split Corp. ("M Split") declares its monthly distribution of $0.03125 per share ($0.375 annually) for Class I Preferred shareholders. The Class I Preferred share dividends are paid at an annual rate of 7.50% based on the $5 notional issue price. Distributions are payable November 10, 2020 to shareholders on record as at October 30, 2020.

M Split invests in common shares of Manulife Financial Corporation, the largest life insurer in Canada offering financial products and wealth management services.

Distribution Details 

Class I Preferred Share (XMF.PR.B)$0.03125
Ex-Dividend Date:October 29, 2020
Record Date:October 30, 2020
Payable Date:November 10, 2020

Investor Relations: 1-877-478-2372
Local: 416-304-4443
www.m-split.com
[email protected]


These press releases may also interest you

at 21:01
TSX VENTURE COMPANIES BULLETIN V2024-2028 BLACKWOLF COPPER AND GOLD LTD. ("BWCG")BULLETIN TYPE:  Plan of Arrangement, Shares for Bonuses, Property-Asset or Share Purchase Agreement, DelistBULLETIN DATE:  July 3, 2024TSX Venture Tier 2 Company Plan of...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:38
Daiso, the renowned global retail chain offering a wide range of affordable and unique products, is thrilled to announce the grand opening of its first Oregon store at Sunset Esplanade in Hillsboro, Oregon on July 20th. "We are thrilled to open our...

at 20:31
Daiso, the renowned global retail chain offering a wide range of affordable and unique products, is thrilled to announce the grand opening at Bay Colony Town Center in League City, Texas on July 13th. "We are thrilled to open our store at Bay Colony...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 18:46
BOXABL, the innovative housing startup known for its foldable Casita homes and building technology, has announced this week that investors have indicated they want to invest over $10MM in the current stock offering. BOXABL previously SOLD OUT the Reg...



News published on and distributed by: